SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-24-022175
Filing Date
2024-07-03
Accepted
2024-07-03 16:06:52
Documents
2
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 8466
2 borgespoa3.txt EX-24 3441
  Complete submission text file 0001437749-24-022175.txt   13278
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Issuer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address
Borges David J. (Reporting) CIK: 0002005787 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34475 | Film No.: 241100103